美国胸科学会临床实践指南:呼出气一氧化氮指导哮喘治疗
美国胸科学会召集国际多学科专家组,针对呼出气一氧化氮(FENO)是否用于指导哮喘治疗这一单一问题,系统综述2004至2019年随机对照试验,采用GRADE框架形成条件性推荐:在考虑调整治疗的哮喘患者中,建议在常规诊疗基础上使用FENO检测。
要点
- 对考虑调整治疗的哮喘患者,建议在常规诊疗基础上加用FENO检测。
- 该推荐为条件性推荐,基于总体低质量证据。
- 推荐平衡了可能有利于干预的效果、中等成本和资源可及性。
核心结论
- 在考虑调整治疗的哮喘患者中,专家组条件性推荐在常规诊疗基础上使用FENO检测。
研究设计与样本
- 国际多学科专家组针对单一问题形成共识文件,系统综述2004至2019年随机对照试验,并采用GRADE证据到决策框架制定推荐。
主要发现
- 专家组考虑总体证据质量低,认为效果平衡可能有利于干预。
- 中等成本与资源可及性可能有利于干预,且干预在日常实践中的可接受性和可行性被认可。
关键数值与推荐
- 条件性推荐:在考虑调整治疗的哮喘患者中,建议在常规诊疗基础上加用FENO检测。
临床怎么用
- 临床医生可依据当前最佳证据,对考虑调整治疗的哮喘患者检测FENO以辅助治疗决策。
局限性
- 总体证据质量低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: The fractional exhaled nitric oxide (FENO) test is a point-of-care test that is used in the assessment of asthma. Objective: To provide evidence-based clinical guidance on whether FENO testing is indicated to optimize asthma treatment in patients with asthma in whom treatment is being considered. Methods: An international, multidisciplinary panel of experts was convened to form a consensus document regarding a single question relevant to the use of FENO. The question was selected from three potential questions based on the greatest perceived impact on clinical practice and the unmet need for evidence-based answers related to this question. The panel performed systematic reviews of published randomized controlled trials between 2004 and 2019 and followed the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) evidence-to-decision framework to develop recommendations. All panel members evaluated and approved the recommendations. Main Results: After considering the overall low quality of the evidence, the panel made a conditional recommendation for FENO-based care. In patients with asthma in whom treatment is being considered, we suggest that FENO is beneficial and should be used in addition to usual care. This judgment is based on a balance of effects that probably favors the intervention; the moderate costs and availability of resources, which probably favors the intervention; and the perceived acceptability and feasibility of the intervention in daily practice. Conclusions: Clinicians should consider this recommendation to measure FENO in patients with asthma in whom treatment is being considered based on current best available evidence.
引用
- Khatri SB, Iaccarino JM, Barochia A, et al. Use of Fractional Exhaled Nitric Oxide to Guide the Treatment of Asthma: An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2021. PMID: 34779751. doi:10.1164/rccm.202109-2093ST
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。